Loading...

APGE APOGEE THERAPEUTICS INC Expansion Plans 8-K Filing

PG T

PG

APOGEE THERAPEUTICS INC

(APGE)

2025 8-K

Show Summary

Show Summary

Clinical Trials

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Meeting Results

Appointment of Director

Earnings Report

Presentation of Phase 1 Data

Financial Results and Phase...

Financial Results Announcement

Appointment of Mark C. McKe...

External Links:

On March 10, 2025, Apogee Therapeutics entered into a Master Services Agreement with Samsung Biologics for the manufacturing of the APG777 drug, effective February 28, 2025, with minimum purchase commitments and potential exit fees.

AI Assistant

APOGEE THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.